secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001906324-23-000030
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q1 revenue $846.1M, down 16%; GAAP EPS $0.73, adjusted EPS $1.80
----------------------------------------------------------------

- Total revenue $846.1M, down 16% YoY; non-respiratory up 5% on supplemental combined basis.
- GAAP EPS $0.73 vs $11.31; adjusted EPS $1.80 vs $8.03 on combined basis, down 78%.
- Labs business drove non-respiratory growth with double-digit growth; respiratory revenue down 72%.
- Adjusted EBITDA $245.3M (29% margin) vs $780.8M (52% margin) in prior year.
- Integration on track; guidance to be provided on conference call; expects sustainable high-single-digit growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000030/0001906324-23-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000030/qdel-20230503.htm
  HTML page:      https://secwatch.observer/filing/0001906324-23-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer